Dogwood Therapeutics, Inc.

DWTX

$193M

Micro Cap

NASDAQBiotechnology🇺🇸North America12 employees

Drugs in Pipeline

Phase 3 Programs

Upcoming Catalysts

Next Catalyst

Jul 15, 2026

29w

Drug Pipeline

Drug Name	Phase	Indication	Designations
Halneuron	Phase 2	Chemotherapy Induced Neuropathic Pain	-

Catalyst Timeline

1 upcoming, 0 past

Phase 2Next

July 2026~Halneuron

Primary completion for Halneuron trial (NCT06848348) in Chemotherapy Induced Neuropathic Pain

Regulatory Approvals

DWTX News